X
AZ sells rights to three older drugs to Covis for $350m
https://pharmaphorum.com/news/az-sells-rights-to-three-older-drugs-to-covis-for-350m/
inflammation
FDA approves two biggest new drugs of 2017
Sales of MS and eczema drugs could top $4bn by 2022
Janssen’s RA candidate among hot topics at EULAR
But attendees warned to expect “oceanic” weather.
